-
1 Comment
From a valuation standpoint, the stock is 90.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.0.
Based on the above factors, JD Health International Inc gets an overall score of 1/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | KYG5074A1004 |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| PE Ratio | 27.1 |
|---|---|
| Market Cap | 124B |
| Target Price | 43.1585 |
| Beta | 1.08 |
| Dividend Yield | None |
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6618.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
